Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - VACCINOGEN INC | v360023_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - VACCINOGEN INC | v360023_ex31-2.htm |
| 10-Q - FORM 10-Q - VACCINOGEN INC | v360023_10q.htm |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Michael G. Hanna, Jr., Ph.D., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Vaccinogen, Inc. on Form 10-Q for the period ended September 30, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Vaccinogen, Inc.
Date: November 13, 2013
|
|
By: |
/s/ Michael G. Hanna, Jr., Ph.D. |
|
|
Name: |
Michael G. Hanna, Jr., Ph.D. |
|
|
Title: |
Chief Executive Officer |
I, Andrew Tussing, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Vaccinogen, Inc. on Form 10-Q for the period ended September 30, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Vaccinogen, Inc.
Date: November 13, 2013
|
|
By: |
/s/ Andrew Tussing |
|
|
Name: |
Andrew Tussing |
|
|
Title: |
Acting Chief Financial Officer |